Lanean...
BRCA1 loses the ring but lords over resistance
Germline breast cancer 1 (BRCA1) variants are associated with a high risk of breast and ovarian cancers. Many BRCA1-mediated cancers are initially responsive to platinum-based therapy; however, resistance commonly develops. The BRCA1(185delAG) mutation is common in the Ashkenazi Jewish population an...
Gorde:
| Argitaratua izan da: | J Clin Invest |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Society for Clinical Investigation
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966308/ https://ncbi.nlm.nih.gov/pubmed/27454288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI89209 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|